Patents Assigned to Merck Patent GmbH
  • Publication number: 20210322285
    Abstract: The present invention relates to a pigment mixture based on spherical particles having a defined particle-size distribution, and to the use thereof in paints, coatings, printing inks, security printing inks, plastics, ceramic materials, glasses, in cosmetic formulations, as tracer, as filler and for the preparation of pigment preparations and dry preparations.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: Merck Patent GmbH
    Inventors: Sylke KLEIN, Lilia HEIDER, Carsten LORENZ, Sabine SCHOEN
  • Publication number: 20210317323
    Abstract: The present invention relates to a composition and to a method of manufacturing a composition.
    Type: Application
    Filed: July 31, 2019
    Publication date: October 14, 2021
    Applicant: Merck Patent GmbH
    Inventors: Tadashi KISHIMOTO, Yuko ARAI, Masayoshi SUZUKI, Daishi YOKOYAMA, Katsuto TANIGUCHI
  • Publication number: 20210317259
    Abstract: The present invention relates to fluorine compounds (I), (II) and (III), to processes for the preparation thereof, and to the use thereof.
    Type: Application
    Filed: June 24, 2021
    Publication date: October 14, 2021
    Applicant: Merck Patent GmbH
    Inventors: Reiner FRIEDRICH, Fabian KOCH
  • Publication number: 20210317145
    Abstract: ?-Amino boronic acid derivatives are useful for inhibiting the activity of immunoproteasome (LMP7) and for the treatment and/or prevention of a medical condition affected by immunoproteasome activity, such as an inflammatory and autoimmune disease, a neurodegenerative disease, a proliferative disease, and cancer.
    Type: Application
    Filed: July 23, 2019
    Publication date: October 14, 2021
    Applicant: Merck Patent GmbH
    Inventors: Markus Klein, Oliver Schadt, Philipp Haselmayer
  • Patent number: 11142649
    Abstract: The present invention relates to alumina flakes having a defined thickness and particle size distribution and to their use in varnishes, paints, automotive coatings printing inks, masterbatches, plastics and cosmetic formulations and as substrate for effect pigments. and organic dyes.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: October 12, 2021
    Assignee: Merck Patent GmbH
    Inventors: Ryuta Suzuki, Gerhard Pfaff, Sabine Schoen, Fumiko Sasaki, Satoru Kobayashi, Koshiro Kunii, Yuji Takenaka, Katsuhisa Nitta
  • Patent number: 11145828
    Abstract: The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: October 12, 2021
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Nils Koenen, Christian Ehrenreich
  • Patent number: 11136343
    Abstract: The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: October 5, 2021
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Christian Ehrenreich, Philipp Harbach, Anna Hayer, Esther Breuning
  • Patent number: 11137639
    Abstract: The invention relates to a switchable optical device (10) having a layer structure comprising at least one switchable layer (15) and at least one optical layer (20, 22). The at least one switchable layer (15) comprises a liquid-crystalline material and at least one dye. The at least one optical layer (20, 22) has at least one reflection band (32) which includes at least a first part of the visible spectrum and has at least one transmission band (30, 34) which includes at least a second part of the visible spectrum. The absorption spectrum of the at least one switchable layer (15) is adjusted by means of the at least one dye such that the light transmission through the switchable optical device (10) for incident light in the visible light spectrum for at least one of the states of the switchable layer (15) is set to a predetermined transmission spectrum.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: October 5, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Ties De Jong, Casper Van Oosten
  • Publication number: 20210300940
    Abstract: Compounds of Formula (I) and pharmaceutically acceptable compositions thereof are useful as TLR7/8 antagonists.
    Type: Application
    Filed: July 29, 2019
    Publication date: September 30, 2021
    Applicant: Merck Patent GmbH
    Inventors: Brian Sherer, Ruoxi Lan, Nadia Brugger, Xiaoling Chen, Momar Toure, Esther Cleary, Lizbeth Celeste Deselm, Yanping Wang
  • Patent number: 11130818
    Abstract: The present invention provides novel peptide sequences for use in microbial transgluatminase-mediated, in particular mTG2-mediated bioconjugations, in particular for the manufacture of antibody-drug-conjugates. Further disclosed are bioconjugation methods employing mTG2 and the novel peptide sequence motifs of the invention. The present invention further provides proteins comprising the novel sequence motifs of the invention as well as polynucleotides encoding the same.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: September 28, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Birgit Piater, Ulrich Betz, Harald Kolmar, Vanessa Siegmund
  • Publication number: 20210292644
    Abstract: The present invention relates to a light luminescent particle, use of the light luminescent particle and method for preparation of the light luminescent particle. The present invention further relates to composition, an optical medium, and an optical device and method for preparation of thereof.
    Type: Application
    Filed: September 7, 2017
    Publication date: September 23, 2021
    Applicant: Merck Patent GmbH
    Inventor: Arjan MEIJER
  • Publication number: 20210292651
    Abstract: An electronic switching element is described having, in sequence, a first electrode, a molecular layer bonded to a substrate, and a second electrode. The molecular layer contains compounds of formula I, R1-(A1-Z1)r—B1—(Z2-A2)s-Sp-G, wherein A1, A2, B1, Z1, Z2, Sp, G, r, and s are as defined herein, in which a mesogenic radical is bonded to the substrate via a spacer group, Sp, by means of an anchor group, G. The switching element is suitable for production of components that can operate as a memristive device for digital information storage.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Peer KIRSCH, Andreas RUHL, Marc TORNOW, Achyut BORA
  • Publication number: 20210292652
    Abstract: The invention relates to a compound of formula I, R11, R21, A11, A, Z, X11, X21, Y11, Y12, Sp11, Sp21, o and p have one of the meanings as given in claim 1. The invention further relates to method of production of a compound of formula I, to the use of said compounds in LC media and to LC media comprising one or more compounds of formula I. Further, the invention relates to a method of production of such LC media, to the use of such media in LC devices, and to LC device comprising a LC medium according to the present invention. The present invention further relates to a process for the fabrication such liquid crystal display and to the use of the liquid crystal mixtures according to the invention for the fabrication of such liquid crystal display.
    Type: Application
    Filed: April 18, 2019
    Publication date: September 23, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Lars LIETZAU, Simon SIEMIANOWSKI, Izumi SAITO
  • Patent number: 11124705
    Abstract: The invention relates to a light modulation element comprising a pair of substrates, one or more optical films located on the inner side of one of the substrates, an electrode structure capable of inducing an electric field substantially in parallel to the substrates main plane, and a homogenously aligned liquid crystalline medium which is obtainable from a photoalignment component A) and a liquid-crystalline component B). Furthermore, the invention relates process of production of the light modulation element, to the use of the light modulation element in an electro optical device and to an electro optical device comprising said light modulation element.
    Type: Grant
    Filed: April 17, 2018
    Date of Patent: September 21, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Phil Baker, Rachel Tuffin, Joseph Sargent, Ian Sage
  • Publication number: 20210284812
    Abstract: The present application relates to a method for producing a polycycloolefin layer, to electronic devices produced by such method and comprising such layer as well as to formulations used for making such polycycloolefin layer.
    Type: Application
    Filed: June 25, 2019
    Publication date: September 16, 2021
    Applicant: Merck Patent GmbH
    Inventors: Holger HEIL, Matthias KOCH, Nathan SMITH
  • Publication number: 20210284911
    Abstract: An electro-optical display element in the areas of displays for watches, pocket calculators, large display panels as used in railway stations, airports and sports arenas, displays of portable or desktop computers, navigation systems and video applications, which upon the application of a voltage to the display element achieves that the longitudinal axis of molecules in a liquid-crystalline media orients itself in such a way that the larger of the dielectric constants becomes effective, which electro-optical display element contains two plates of a capacitor.
    Type: Application
    Filed: February 5, 2021
    Publication date: September 16, 2021
    Applicant: Merck Patent GmbH
    Inventors: Volker Reiffenrath, Matthias Bremer, Rocco Fortte, Harald Hirschmann, Martin Engel
  • Publication number: 20210283136
    Abstract: The present invention refers to a crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid L-leucine ethyl ester wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid and L-leucine ethyl ester is from 1:0.3 to 1:3.0 (in mol/mol) and/or hydrates and/or solvates thereof as well as to a process of obtaining the same.
    Type: Application
    Filed: July 2, 2019
    Publication date: September 16, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
  • Publication number: 20210284912
    Abstract: The invention relates to a compound of formula I, wherein R11, R21, A11, A, Z, X11, X21, Y11, Y12, Sp11, Sp21, o and p have one of the meanings as given in claim 1. The invention further relates to method of production of a compound of formula I, to the use of said compounds in LC media and to LC media comprising one or more compounds of formula I. Further, the invention relates to a method of production of such LC media, to the use of such media in LC devices, and to LC device comprising a LC medium according to the present invention. The present invention further relates to a process for the fabrication such liquid crystal display and to the use of the liquid crystal mixtures according to the invention for the fabrication of such liquid crystal display.
    Type: Application
    Filed: April 18, 2019
    Publication date: September 16, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Lars LIETZAU, Simon SIEMIANOWSKI, Izumi SAITO, Rocco FORTTE
  • Patent number: 11118066
    Abstract: The present invention relates to novel compounds containing fluorinated end groups and to the use thereof in, for example, dirt-repellent coatings.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: September 14, 2021
    Assignee: Merck Patent GmbH
    Inventor: Reiner Friedrich
  • Patent number: 11121323
    Abstract: The present invention relates to a compound of the formula (I), (II) or (III), to the use of the compound in an electronic device, and to an electronic device comprising a compound of the formula (I), (II) or (III). The present invention furthermore relates to a process for the preparation of a compound of the formula (I), (II) or (III) and to a formulation comprising one or more compounds of the formula (I), (II) or (III).
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: September 14, 2021
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Arne Buesing, Christof Pflumm, Teresa Mujica-Fernaud, Philipp Stoessel, Thomas Eberle, Frank Voges